Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Multi

DKB Fonds - Pharma Fonds

+ Add to Watchlist

DKEB:GR

62.0900 EUR 0.3600 0.58%

As of 02:09:48 ET on 05/25/2015.

Snapshot for DKB Fonds - Pharma Fonds (DKEB)

Open: 61.8100 High - Low: 62.0900 - 61.8100 Primary Exchange: Berlin
Volume: 0 52-Week Range: 41.6600 - 65.5400 Beta vs MSGUHC: 0.9681

ETF Chart for DKEB

No chart data available.
  • DKEB:GR 62.0900
  • 1M
  • 1Y
62.4500
Interactive DKEB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DKEB

DKB Pharma Fonds is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term growth. The Fund invests in equities issued by pharmaceutical, technology and biotechnology companies in North America and Europe.

Inception Date: 2000-08-30 Telephone: 352-424345464
Managers: MARKUS HAMELLA
Web Site: www.bayerninvest.lu

Fundamentals for DKEB

NAV (on 2015-05-22) 62.4700
Assets (M) (on 2015-05-22) 44.6690
Shares out (M) 0.62
Market Cap (M) 38.76
% Premium -0.03
Average 52-Week % Premium -0.4704
Fund Leveraged N

Dividends for DKEB

No dividends reported

Performance for DKEB

1-Month -2.91% 1-Year +50.52%
3-Month +7.85% 3-Year +29.12%
Year To Date +19.68% 5-Year +21.16%
Expense Ratio 2.51

Top Fund Holdings for DKEB

Filing Date: 04/30/2015
Name Position Value % of Total
Novartis AG 32,933 3,041,189 6.387%
Pfizer Inc 85,500 2,650,450 5.566%
Roche Holding AG 7,850 2,012,046 4.225%
Merck & Co Inc 36,000 1,942,304 4.079%
Sanofi 18,000 1,648,080 3.461%
Gilead Sciences Inc 17,100 1,581,767 3.322%
AbbVie Inc 22,500 1,334,968 2.803%
Amgen Inc 8,900 1,295,233 2.720%
GlaxoSmithKline PLC 61,400 1,293,987 2.717%
Johnson & Johnson 14,000 1,270,587 2.668%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil